Skip to main content
Lyka Labs Ltd. logo

Lyka Labs Ltd. — Investor Relations & Filings

Ticker · LYKALABS ISIN · INE933A01014 LEI · 3358001RHQJBCTT1ER45 BSE.NS Manufacturing
Open in API
Filings indexed 1,205 across all filing types
Latest filing 2021-06-02 Annual Report
Country IN India
Listing BSE.NS LYKALABS

About Lyka Labs Ltd.

https://www.lykalabs.com

Lyka Labs Ltd. specializes in the development, manufacture, and marketing of pharmaceutical formulations and active pharmaceutical ingredients (APIs). The company maintains a diverse product portfolio spanning multiple therapeutic categories, including anti-infectives, dermatologicals, cardiovascular agents, and pain management. A significant area of expertise for the organization is lyophilization technology, enabling the production of high-quality injectable formulations. The company operates advanced manufacturing facilities designed to meet international quality standards, supporting its operations in both domestic and global markets. Its core activities encompass the production of various dosage forms such as tablets, capsules, ointments, and sterile injectables, with a particular focus on specialized segments like cephalosporins and critical care medications.

Recent filings

Filing Released Lang Actions
Updates
Annual Report Classification · 95% confidence The document is a detailed announcement from the Board of Directors dated 02 June 2021, reporting the outcome of a board meeting. It includes the adoption of standalone and consolidated audited financial results and annual accounts for the fiscal year ended 31 March 2021. It also mentions the approval of the Directors' Report and the scheduling of the Annual General Meeting. The document contains detailed financial data such as revenue, expenses, profit/loss figures, and balance sheet items, indicating it is a comprehensive financial report rather than a brief announcement or certification. The presence of full financial statements and analysis for the fiscal year confirms it is an Annual Report. Therefore, the document fits the definition of an Annual Report (10-K). FY 2021
2021-06-02 English
We wish to inform you that the Board of Directors at their meeting held today have decided that; 1. The Annual General Meeting is convened on 30 July, 2021 through Video conferencing ....
Regulatory Filings
2021-06-02 English
Lyka Labs Ltd has informed BSE about Outcome of Board Meeting held on June 02, 2021.
Regulatory Filings
2021-06-02 English
Outcome of Board Meeting
Annual Report Classification · 95% confidence The document is a detailed announcement from the Board of Directors dated 02 June 2021, reporting the outcome of a board meeting. It includes the adoption of standalone and consolidated audited financial results and annual accounts for the fiscal year ended 31 March 2021. It also mentions the approval of the Directors' Report and provides detailed financial data such as revenue, expenses, profit/loss, assets, and equity for the year ended 31 March 2021. The document contains comprehensive financial statements and analysis for the full fiscal year, which is characteristic of an Annual Report. The presence of audited financial results and annual accounts confirms this classification. The document is lengthy (15,000 characters) and contains substantive financial data, so it is not merely an announcement or a certification. Therefore, the appropriate classification is Annual Report (10-K). FY 2021
2021-06-02 English
Financial Result Updates
Annual Report Classification · 95% confidence The document is a detailed announcement from the Board of Directors dated 02 June 2021, reporting the outcome of a board meeting. It includes the adoption of standalone and consolidated audited financial results and annual accounts for the fiscal year ended 31 March 2021. It also mentions the approval of the Directors' Report and the scheduling of the Annual General Meeting. The document contains extensive financial data including quarterly and annual financial results, balance sheet items, and other financial metrics. The presence of comprehensive financial statements and analysis for the full fiscal year indicates this is the actual annual financial report rather than a brief announcement or a certification. Therefore, this document fits the definition of an Annual Report (10-K) rather than a simple announcement or other filing types. FY 2021
2021-06-02 English
Financial Results for the Fourth Quarter and Financial year ended 31 March, 2021
Regulatory Filings
2021-06-02 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.